| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |